Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best mid-cap growth stocks to buy right now. On January 14, Bank of America lowered its price target on Travere Therapeutics to $43 from $47, ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX).
Zacks.com on MSN
Mirum Stock Rises 7% in a Week: Here's What You Should Know
Shares of Mirum Pharmaceuticals MIRM were up 7.1% this past week after the company reported robust preliminary results for ...
The Food and Drug Administration has extended the review period for sparsentan in focal segmental glomerulosclerosis (FSGS).
Nvidia and Eli Lilly unveiled a co-innovation AI Lab for drug discovery efforts. Nvidia announced a strategic collaboration ...
Investor's Business Daily on MSN
Small caps, chips lead stock market; JPMorgan, Goldman Delta, Taiwan Semiconductor in focus: Weekly review
Small caps and chips led the stock market this week. JPMorgan, Goldman Sachs, Delta Air Lines and Taiwan Semiconductor were ...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results